Clinical Trial Update: Parenteral Phenoxybenzamine During Congenital Heart Disease Surgery [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating parenteral phenoxybenzamine in congenital heart disease surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Drugs mentioned

• Phenoxybenzamine (phenoxybenzamine)

Snippet

Sponsor: Vanderbilt University | Conditions: Congenital Heart Disease | Phase 2 | Status: WITHDRAWN